Your partner in oncology


Oncology Therapeutic Development

100 rue Martre
92110 Clichy - FRANCE
Tel:  +33 1 47 15 01 01
Fax: +33 1 45 19 06 59

Contact Us

Doctor Mohamed BEKRADDA

Dr. Bekradda is a board-certified medical oncologist with nearly 30 years of experience in Phase I-III clinical development of anticancer drugs. His focus has been on genitourinary and gastrointestinal cancers. Highlights include therapeutic evaluation in hormone-resistant prostate cancer, development of cisplatin chemotherapy regimens for non-seminomatous germ cell tumors and oxaliplatin regimens of colorectal cancer and NSCLC He has worked with a range of agents, including docetaxel, oxaliplatin, alemtuzumab, capecitabine, trastuzumab and advexin. He has also led onsite reviews for large international compassionate-use cohorts.

Dr. Bekradda has held academic and staff appointments in France at Gustave Roussy), Centre Léon Bérard and the Center Hospitalier Sud Francilien. In 1996, he cofounded CAC with Prof. Cvitkovic. Prior to joining OTD, Dr. Bekradda worked at Hoffmann-La Roche Ltd.